NEWS
DTN VIDEOS WIN AWARD
DIGITAL HEALTH FOR T2S
The Royal College of Physicians (RCP)
has recently announced the winners of
its Excellence in Patient Care Awards
2020. Colleagues at the Association of
British Clinical Diabetologists (ABCD) led
by Dr Emma Wilmot have won the digital
award for the Flash Glucose Collaboration
between ABCD, the Diabetes Technology
Network UK and NHS England.
The RCP award recognises and
rewards the use of new or existing
technologies or digitally-driven projects
that have contributed to significant
improvements in patient care or health
outcomes. Prize money has been
donated to Life for a Child Spare a Rose
campaign, which gives insulin to children
in need across the globe.
See the video series here:
abcd.care/dtn/education
Dexcom and Ypsomed have announced
a partnership to drive the development of
a hybrid closed loop system, an important
milestone in the further development of
individualised diabetes therapy. In a first
step, CGM data from Dexcom will be
integrated into Ypsomed's mylife app.
The partnership means the full integration
of glucose values from Dexcom's
G6 sensors into Ypsomed's therapy
management solution.
Users of Dexcom CGM and the mylife
(sic) YpsoPump insulin pump can expect
all therapy-relevant data in the mylife app
on their smartphone. Also, every five
minutes, the CGM sensor will send the
current glucose values to the mylife app,
where the current glucose reading and
trend graph will be displayed. The mylife
app will alert its users when glucose values
are too high or too low. Configuration and
sensor settings will be available directly in
the mylife app and users will be able to
send their CGM and insulin pump data
wirelessly from the mylife app to the mylife
cloud and share it with their diabetes team
or caregivers.
The integration is expected to be
available in late 2020 / early 2021 in
Europe, by a simple update of the mylife
app and no need to replace the current
insulin pump.
Integrating Dexcom CGM data is a
significant step forward in Ypsomed's
mylife loop program. The goal of the
program is a modular and therefore
customizable diabetes therapy system
with an insulin pump completely
controllable via the smartphone, and the
future option of adding a hybrid closed
loop feature powered by the Dexcom
TypeZero algorithm. The smartphone
approach enables feature-upgrades
without the need to exchange the insulin
pump hardware.
HYBRID SYSTEM
PROGRESS
A campaign group has urged that a
powerful, industry-funded group is
playing an "outsized role" in steering
the development of new US dietary
guidelines and must have its influence
curbed to protect public health. Corporate
Accountability published a report to
coincide with Coca-Cola's annual meeting
of shareholders. It noted that over half of
people appointed to the US 2020 Dietary
Guidelines Advisory Committee had ties
to the International Life Sciences Institute
(ILSI). Its funders include Coke and other
global corporations. The report found
that across Latin America, ILSI also has a
strong influence in stifling progress to curb
obesity, diabetes, and other diet-related
diseases.
"It's time for Coke to put something
more on ice than its soft drinks," said
Corporate Accountability Research
Director Ashka Naik, co-author of the
report. "Coke is telling investors it cares
about public health on the one hand,
but funds ILSI to block public health
safeguards on the other. Its misleading of
investors and consumers is a liability that
will only grow."
Read the report HERE.
Nominations for Quality in Care (QiC)
Diabetes awards are now open.
If you know of someone who's doing
a great job in the arena of diabetes
care, maybe you can get someone the
recognition they deserve. Categories you
can nominate in are Diabetes Professional
of the Year; Outstanding Educator in
Diabetes and The People's Award.
The People's Award, supported by
Diabetes UK, recognises an individual
who has supported/cared for people with
diabetes. It will be presented to someone
who is based in the UK or Ireland and
is not a healthcare professional. It can
be anyone that you think deserves this
recognition, such as a carer, volunteer, a
person with diabetes, diabetes blogger
and/or writer, family member.
The closing date is 2 July 2020, while
the awards ceremony is due to take place
at Sanofi's Reading headquarters on 15
October 2020.
Find out more, including how to
nominate at
qualityincare.org/diabetes
QIC: NOMINATE YOUR HERO